METTL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 3.799400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
2.792000E-01
Normal-vs-Stage2
3.813600E-01
Normal-vs-Stage3
2.455200E-01
Normal-vs-Stage4
2.725000E-01
Stage1-vs-Stage2
2.322800E-01
Stage1-vs-Stage3
4.719900E-02
Stage1-vs-Stage4
5.375600E-01
Stage2-vs-Stage3
2.782100E-02
Stage2-vs-Stage4
9.236000E-01
Stage3-vs-Stage4
2.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
3.876000E-01
Normal-vs-AfricanAmerican
3.565800E-01
Normal-vs-Asian
3.035000E-01
Caucasian-vs-AfricanAmerican
6.005000E-01
Caucasian-vs-Asian
6.103700E-02
AfricanAmerican-vs-Asian
3.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
3.767200E-01
Normal-vs-Female
3.852200E-01
Male-vs-Female
7.357000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
5.790400E-01
Normal-vs-Age(41-60Yrs)
4.213000E-01
Normal-vs-Age(61-80Yrs)
3.578800E-01
Normal-vs-Age(81-100Yrs)
3.697800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.811420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.471700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.110400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.264000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.973200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.385600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
3.717600E-01
Normal-vs-Daily Drinker
3.753800E-01
Normal-vs-Weekly Drinker
3.580000E-01
Normal-vs-Occasional Drinker
3.704800E-01
Normal-vs-Social Drinker
4.808400E-01
Non Drinker-vs-Daily Drinker
9.675200E-01
Non Drinker-vs-Weekly Drinker
7.705200E-01
Non Drinker-vs-Occasional Drinker
9.763200E-01
Non Drinker-vs-Social Drinker
5.672100E-02
Daily Drinker-vs-Weekly Drinker
7.816400E-01
Daily Drinker-vs-Occasional Drinker
9.501000E-01
Daily Drinker-vs-Social Drinker
8.532400E-02
Weekly Drinker-vs-Occasional Drinker
7.896600E-01
Weekly Drinker-vs-Social Drinker
5.222100E-02
Occasional Drinker-vs-Social Drinker
3.831700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
8.338800E-01
Normal-vs-Grade 2
9.755200E-01
Normal-vs-Grade 3
9.835200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.310400E-01
Grade 1-vs-Grade 3
5.414000E-01
Grade 1-vs-Grade 4
8.338800E-01
Grade 2-vs-Grade 3
2.612000E-01
Grade 2-vs-Grade 4
9.755200E-01
Grade 3-vs-Grade 4
9.835200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
3.614200E-01
Normal-vs-NonDiabetic
3.780800E-01
Diabetic-vs-NonDiabetic
5.465200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
3.723200E-01
Normal-vs-NoPancreatitis
3.683600E-01
Pancreatitis-vs-NoPancreatitis
9.823800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
3.790200E-01
Normal-vs-N1
3.779000E-01
N0-vs-N1
9.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
3.770800E-01
Normal-vs-TP53-NonMutant
4.147400E-01
TP53-Mutant-vs-TP53-NonMutant
3.215000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap